Zaryouh, H.; Van Loenhout, J.; Peeters, M.; Vermorken, J.B.; Lardon, F.; Wouters, A.
Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy? Cancers 2022, 14, 6128.
https://doi.org/10.3390/cancers14246128
AMA Style
Zaryouh H, Van Loenhout J, Peeters M, Vermorken JB, Lardon F, Wouters A.
Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy? Cancers. 2022; 14(24):6128.
https://doi.org/10.3390/cancers14246128
Chicago/Turabian Style
Zaryouh, Hannah, Jinthe Van Loenhout, Marc Peeters, Jan Baptist Vermorken, Filip Lardon, and An Wouters.
2022. "Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?" Cancers 14, no. 24: 6128.
https://doi.org/10.3390/cancers14246128
APA Style
Zaryouh, H., Van Loenhout, J., Peeters, M., Vermorken, J. B., Lardon, F., & Wouters, A.
(2022). Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy? Cancers, 14(24), 6128.
https://doi.org/10.3390/cancers14246128